{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:23:55Z","timestamp":1787379835745,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00886-w","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:14:23Z","timestamp":1784862863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical correlates of autoimmune and infection-related antibodies in unexplained seizures in western China"],"prefix":"10.1186","volume":"27","author":[{"given":"Yushan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"2","key":"886_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1684\/epd.2018.0957","volume":"20","author":"MJ Brodie","year":"2017","unstructured":"Brodie MJ, Zuberi SM, Scheffer IE, et al. The 2017 ILAE classification of seizure types and the epilepsies: what do people with epilepsy and their caregivers need to know?[J]. Epileptic Disord. 2017;20(2):77\u201387.","journal-title":"Epileptic Disord"},{"issue":"4","key":"886_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia. 2017;58(4):522\u201330.","journal-title":"Epilepsia"},{"issue":"10399","key":"886_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(23)01048-6","volume":"402","author":"AA Asadi-Pooya","year":"2023","unstructured":"Asadi-Pooya AA, Brigo F, Lattanzi S, et al. Adult epilepsy[J]. Lancet. 2023;402(10399):412\u201324.","journal-title":"Lancet"},{"issue":"4","key":"886_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia. 2017;58(4):512\u201321.","journal-title":"Epilepsia"},{"issue":"2","key":"886_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40265-022-01826-9","volume":"83","author":"J Flammer","year":"2023","unstructured":"Flammer J, Neziraj T, R\u00fcEGG S, et al. Immune mechanisms in epileptogenesis: update on diagnosis and treatment of autoimmune epilepsy syndromes[J]. Drugs. 2023;83(2):135\u201358.","journal-title":"Drugs"},{"key":"886_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.seizure.2021.07.005","volume":"91","author":"L Chen","year":"2021","unstructured":"Chen L, Zhu L, Lu D, et al. Association between autoimmune encephalitis and epilepsy: systematic review and meta-analysis[J]. Seizure. 2021;91:346\u201359.","journal-title":"Seizure"},{"issue":"6","key":"886_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41582-025-01089-4","volume":"21","author":"C Steriade","year":"2025","unstructured":"Steriade C, Bauer J, Bien CG. Autoimmune encephalitis-associated epilepsy[J]. Nat Rev Neurol. 2025;21(6):312\u201326.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"886_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","volume":"61","author":"C Steriade","year":"2020","unstructured":"Steriade C, Britton J, Dale RC, et al. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions[J]. Epilepsia. 2020;61(7):1341\u201351.","journal-title":"Epilepsia"},{"issue":"9","key":"886_CR9","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/epi.17699","volume":"64","author":"A Rada","year":"2023","unstructured":"Rada A, Bien CG. What is autoimmune encephalitis-associated epilepsy? Proposal of a practical definition[J]. Epilepsia. 2023;64(9):2249\u201355.","journal-title":"Epilepsia"},{"issue":"3","key":"886_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","volume":"16","author":"KS Husari","year":"2019","unstructured":"Husari KS, Dubey D. Autoimmune epilepsy[J]. Neurotherapeutics. 2019;16(3):685\u2013702.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"886_CR11","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/epi4.70159","volume":"10","author":"IT Lin","year":"2025","unstructured":"Lin IT, Shen C, Chung CT, et al. Defining the role of systemic autoimmune markers in adult epilepsy: a focus on autoimmune-associated epilepsy[J]. Epilepsia Open. 2025;10(6):1905\u201317.","journal-title":"Epilepsia Open"},{"issue":"4","key":"886_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","volume":"74","author":"D Dubey","year":"2017","unstructured":"Dubey D, Alqallaf A, Hays R, et al. Neurological autoantibody prevalence in epilepsy of unknown etiology[J]. JAMA Neurol. 2017;74(4):397\u2013402.","journal-title":"JAMA Neurol"},{"key":"886_CR13","doi-asserted-by":"crossref","unstructured":"Cabezudo-Garc\u00eda P, Mena-V\u00e1zquez N, Ciano-Petersen NL, et al. Prevalence of neural autoantibodies in epilepsy of unknown etiology: systematic review and meta-analysis[J]. Brain Sci. 2021;11(3)392.","DOI":"10.3390\/brainsci11030392"},{"issue":"8","key":"886_CR14","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1007\/s00415-021-10457-1","volume":"268","author":"M Goudot","year":"2021","unstructured":"Goudot M, Frismand S, Hopes L, et al. Recurrent seizures of autoimmune origin: emerging phenotypes[J]. J Neurol. 2021;268(8):3000\u201310.","journal-title":"J Neurol"},{"issue":"5","key":"886_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","volume":"71","author":"MS Ong","year":"2014","unstructured":"Ong MS, Kohane IS, Cai T, et al. Population-level evidence for an autoimmune etiology of epilepsy[J]. JAMA Neurol. 2014;71(5):569\u201374.","journal-title":"JAMA Neurol"},{"key":"886_CR16","doi-asserted-by":"crossref","unstructured":"Matricardi S, Casciato S, Bozzetti S, et al. Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy[J]. J Neurol Neurosurg Psychiatry. 2022;93:1194\u2013201.jnnp-2022-329195.","DOI":"10.1136\/jnnp-2022-329195"},{"issue":"8","key":"886_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/acn3.51137","volume":"7","author":"CH Shen","year":"2020","unstructured":"Shen CH, Fang GL, Yang F, et al. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA(B) R encephalitis[J]. Ann Clin Transl Neurol. 2020;7(8):1392\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"886_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.seizure.2023.12.018","volume":"115","author":"K Zhou","year":"2024","unstructured":"Zhou K, Zhang L, Shen S, et al. Neurological autoantibody prevalence in chronic epilepsy: clinical and neuropathologic findings[J]. Seizure. 2024;115:28\u201335.","journal-title":"Seizure"},{"issue":"19","key":"886_CR19","doi-asserted-by":"publisher","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","volume":"92","author":"M de Bruijn","year":"2019","unstructured":"de Bruijn M, van Sonderen A, Van Coevorden-Hameete MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA(B)R encephalitis[J]. Neurology. 2019;92(19):e2185\u201396.","journal-title":"Neurology"},{"issue":"11","key":"886_CR20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/RLU.0000000000004848","volume":"48","author":"BJ Burkett","year":"2023","unstructured":"Burkett BJ, Johnson DR, Hunt CH, et al. Anti-LGI1 autoimmune epilepsy[J]. Clin Nucl Med. 2023;48(11):956\u20137.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"886_CR21","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/epi.17245","volume":"63","author":"X Liu","year":"2022","unstructured":"Liu X, Guo K, Lin J, et al. Long-term seizure outcomes in patients with autoimmune encephalitis: a prospective observational registry study update[J]. Epilepsia. 2022;63(7):1812\u201321.","journal-title":"Epilepsia"},{"issue":"4","key":"886_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1055\/s-0036-1585453","volume":"36","author":"J Linnoila","year":"2016","unstructured":"Linnoila J, Pittock SJ. Autoantibody-associated central nervous system neurologic disorders[J]. Semin Neurol. 2016;36(4):382\u201396.","journal-title":"Semin Neurol"},{"key":"886_CR23","doi-asserted-by":"publisher","first-page":"725950","DOI":"10.3389\/fimmu.2021.725950","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zhang Y, Cui L, et al. Presence of anti-thyroid antibodies correlate to worse outcome of anti-NMDAR encephalitis[J]. Front Immunol. 2021;12:725950.","journal-title":"Front Immunol"},{"key":"886_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577324","volume":"347","author":"G Culler","year":"2020","unstructured":"Culler G, Bachman E, Vanhaerents S. Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis[J]. J Neuroimmunol. 2020;347:577324.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"886_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/ene.14077","volume":"27","author":"L Hopia","year":"2020","unstructured":"Hopia L, Andersson M, Svenungsson E, et al. Epilepsy in systemic lupus erythematosus: prevalence and risk factors[J]. Eur J Neurol. 2020;27(2):297\u2013307.","journal-title":"Eur J Neurol"},{"issue":"3","key":"886_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/cns.13562","volume":"27","author":"Z Guo","year":"2021","unstructured":"Guo Z, He X, Zhang G, et al. Hashimoto\u2019s encephalopathy: a rare cause of refractory status epilepticus[J]. CNS Neurosci Ther. 2021;27(3):372\u20135.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"886_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11845-018-1777-2","volume":"187","author":"M Tecellioglu","year":"2018","unstructured":"Tecellioglu M, Kamisli O, Kamisli S, et al. Neurological autoantibodies in drug-resistant epilepsy of unknown cause[J]. Ir J Med Sci. 2018;187(4):1057\u201363.","journal-title":"Ir J Med Sci"},{"key":"886_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.seizure.2021.11.010","volume":"94","author":"TS Ilia","year":"2022","unstructured":"Ilia TS, Dragoumi P, Papanikolopoulou S, et al. Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis[J]. Seizure. 2022;94:117\u201325.","journal-title":"Seizure"},{"issue":"4","key":"886_CR29","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/brain\/awad419","volume":"147","author":"J Cleaver","year":"2024","unstructured":"Cleaver J, Jeffery K, Klenerman P, et al. The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity[J]. Brain. 2024;147(4):1130\u201348.","journal-title":"Brain"},{"issue":"3","key":"886_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0529-1","volume":"15","author":"A Venkatesan","year":"2015","unstructured":"Venkatesan A, Benavides DR. Autoimmune encephalitis and its relation to infection[J]. Curr Neurol Neurosci Rep. 2015;15(3):3.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"886_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy[J]. Acta Neuropathol. 2016;131(2):211\u201334.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"886_CR32","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1093\/brain\/awad238","volume":"146","author":"T Armangu\u00e9","year":"2023","unstructured":"Armangu\u00e9 T, Oliv\u00e9-Cirera G, Mart\u00ednez-Hernandez E, et al. Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies[J]. Brain. 2023;146(10):4306\u201319.","journal-title":"Brain"},{"key":"886_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbi.2025.04.026","volume":"128","author":"TL Baker","year":"2025","unstructured":"Baker TL, Wright DK, Thergarajan P, et al. A pre-existing chronic Toxoplasma gondii infection promotes epileptogenesis and neuropathology in a mouse model of mesial temporal lobe epilepsy[J]. Brain Behav Immun. 2025;128:440\u201355.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"886_CR34","first-page":"3365","volume":"168","author":"GL Carrillo","year":"2024","unstructured":"Carrillo GL, Su J, Cawley ML, et al. Complement-dependent loss of inhibitory synapses on pyramidal neurons following Toxoplasma gondii infection[J]. J Neurochem. 2024;168(10):3365\u201385.","journal-title":"J Neurochem"},{"issue":"11","key":"886_CR35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/jnnp-2020-323841","volume":"91","author":"S Bozzetti","year":"2020","unstructured":"Bozzetti S, Rossini F, Ferrari S, et al. Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study[J]. J Neurol Neurosurg Psychiatry. 2020;91(11):1145\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"886_CR36","doi-asserted-by":"publisher","first-page":"114558","DOI":"10.1016\/j.intimp.2025.114558","volume":"154","author":"Y Dai","year":"2025","unstructured":"Dai Y, Han B, Yuan T, et al. Antibody prevalence and validation of APE2 and ACES in epilepsy patients with suspected autoimmune origin: a retrospective study[J]. Int Immunopharmacol. 2025;154:114558.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"886_CR37","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1111\/epi.17238","volume":"63","author":"YC Chang","year":"2022","unstructured":"Chang YC, Nouri MN, Mirsattari S, et al. \u201cObvious\u201d indications for neural antibody testing in epilepsy or seizures: the ONES checklist[J]. Epilepsia. 2022;63(7):1658\u201370.","journal-title":"Epilepsia"},{"issue":"24","key":"886_CR38","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1097\/CM9.0000000000001701","volume":"134","author":"Y Jia","year":"2021","unstructured":"Jia Y, Wang HF, Zhang MY, et al. Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies[J]. Chin Med J (Engl). 2021;134(24):2985\u201391.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"886_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models[J]. Lancet Neurol. 2019;18(11):1045\u201357.","journal-title":"Lancet Neurol"},{"issue":"6","key":"886_CR40","doi-asserted-by":"publisher","first-page":"e200469","DOI":"10.1212\/NXI.0000000000200469","volume":"12","author":"T Baumgartner","year":"2025","unstructured":"Baumgartner T, Freyberg M, Campetella L, et al. Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients[J]. Neurol Neuroimmunol Neuroinflamm. 2025;12(6):e200469.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"886_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01142","volume":"10","author":"J Zhao","year":"2019","unstructured":"Zhao J, Wang C, Xu X, et al. Coexistence of autoimmune encephalitis and other systemic autoimmune diseases[J]. Front Neurol. 2019;10:1142.","journal-title":"Front Neurol"},{"key":"886_CR42","doi-asserted-by":"publisher","first-page":"1028290","DOI":"10.3389\/fneur.2022.1028290","volume":"13","author":"SH Chen","year":"2022","unstructured":"Chen SH, O\u2019dea PK, Sianati B, et al. Role of responsive neurostimulation and immunotherapy in refractory epilepsy due to autoimmune encephalitis: a case report[J]. Front Neurol. 2022;13:1028290.","journal-title":"Front Neurol"},{"issue":"2","key":"886_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/NRL.0000000000000652","volume":"31","author":"H Pump","year":"2026","unstructured":"Pump H, Feyissa AM. Early Institution of Immunotherapy Alters the Course of Temporal Lobe Epilepsy With GAD65 Antibody: A Clinical Report[J]. Neurologist. 2026;31(2):49\u201352.","journal-title":"Neurologist"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00886-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:41:42Z","timestamp":1787377302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00886-w","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of West China Hospital of Sichuan University (approval number: ChiCTR1900027074), and was conducted in compliance with the Declaration of Helsinki, and the requirement for written informed consent was waived due to the retrospective design of the research. Patient data were anonymized prior to analysis by removing all direct identifiers (names, medical record numbers, and contact information) and assigning unique study codes.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"77"}}